When a single gene was used for CRC detection using plasma samples, PPP1R3C gave better results than EFHD1. For PPP1R3C, 97 (81% sensitivity) of 120 CRC patients and 78 (81% specificity) of 96 noncancer patients were diagnosed correctly. This evidence concerns the gene PPP1R3C and colorectal carcinoma.